Evidence map›Paper›PMID 29988683›Full record

ArticleThe journal of venomous animals and toxins including tropical diseases2018

Mass fingerprinting and electrophysiological analysis of the venom from the scorpion

Laura L Valdez-Velázquez, Timoteo Olamendi-Portugal, Rita Restano-Cassulini, Fernando Z Zamudio, Lourival D Possani

Open access · goldAbstract read
In one paragraph

Article in The journal of venomous animals and toxins including tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Laura L Valdez-Velázquez1Facultad de Ciencias Químicas, Universidad de Colima, Coquimatlan, Colima, Mexico.
Timoteo Olamendi-Portugal2Instituto de Biotecnología, Universidad Nacional Autónoma de México, Avenida Universidad 2001, Colonia Chamilpa, apartado postal, 510-3 Cuernavaca, Morelos Mexico.
Rita Restano-Cassulini2Instituto de Biotecnología, Universidad Nacional Autónoma de México, Avenida Universidad 2001, Colonia Chamilpa, apartado postal, 510-3 Cuernavaca, Morelos Mexico.
Fernando Z Zamudio2Instituto de Biotecnología, Universidad Nacional Autónoma de México, Avenida Universidad 2001, Colonia Chamilpa, apartado postal, 510-3 Cuernavaca, Morelos Mexico.
Lourival D Possani2Instituto de Biotecnología, Universidad Nacional Autónoma de México, Avenida Universidad 2001, Colonia Chamilpa, apartado postal, 510-3 Cuernavaca, Morelos Mexico.ORCID 0000-0001-6357-2661
Universidad Autónoma del Estado de Morelos · MXUniversidad de Colima · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsFingerprinting mass analysis of the soluble venom from this scorpion was achieved by high-performance liquid chromatography and electrospray mass spectrometry. Furthermore, the soluble venom and its toxic effects were evaluated extensively via electrophysiological assays in HEK cells expressing human voltage-gated Na

resultsThe separation of soluble venom produced 60 fractions from which 83 distinct components were identified. The molecular mass distribution of these components varies from 340 to 21,120 Da. Most of the peptides have a molecular weight between 7001 and 8000 Da (46% components), a range that usually corresponds to peptides known to affect Na

conclusionThe venom contains more than 83 distinct components, among which are peptides that affect the function of human Na

Indexed as

CentruroidesElectrophysiologyMass fingerprintingScorpion venom

Identifiers

PMID29988683
PMCPMC6029114
OpenAlexW2811411163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.